Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 EGFR mutations and sensitivity to gefitinib.

Literature DB >> 15376352

EGFR mutations and sensitivity to gefitinib.

Jeremy N Rich, B K Ahmed Rasheed, Hai Yan.

Abstract

Entities: Chemical Gene

Mesh：

Substances：

Year: 2004 PMID： 15376352

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

23 in total

Review 1. Adipocyte and lipid metabolism in cancer drug resistance.

Authors: Yihai Cao
Journal: J Clin Invest Date: 2019-07-02 Impact factor: 14.808

2. Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384.

Authors: Yanni Zhu; Khalid Shah
Journal: Cancer Biol Ther Date: 2014-03-21 Impact factor: 4.742

3. Analysis of EGFR gene amplification, protein over-expression and tyrosine kinase domain mutation in recurrent glioblastoma.

Authors: Judit Toth; Kristof Egervari; Almos Klekner; Laszlo Bognar; Janos Szanto; Zoltan Nemes; Zoltan Szollosi
Journal: Pathol Oncol Res Date: 2008-08-28 Impact factor: 3.201

Review 4. Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance.

Authors: T E Taylor; F B Furnari; W K Cavenee
Journal: Curr Cancer Drug Targets Date: 2012-03 Impact factor: 3.428

5. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.

Authors: Tejus A Bale; Justin T Jordan; Otto Rapalino; Nisha Ramamurthy; Nicholas Jessop; John C DeWitt; Valentina Nardi; Maria Martinez-Lage Alvarez; Matthew Frosch; Tracy T Batchelor; David N Louis; A John Iafrate; Daniel P Cahill; Jochen K Lennerz
Journal: Neuro Oncol Date: 2019-05-06 Impact factor: 12.300

Review 6. Targeted molecular therapy of malignant gliomas.

Authors: Santosh Kesari; Naren Ramakrishna; Claire Sauvageot; Charles D Stiles; Patrick Y Wen
Journal: Curr Neurol Neurosci Rep Date: 2005-05 Impact factor: 5.081

7. Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma.

Authors: Alberto Broniscer; Suzanne J Baker; Clinton F Stewart; Thomas E Merchant; Fred H Laningham; Paula Schaiquevich; Mehmet Kocak; E Brannon Morris; Raelene Endersby; David W Ellison; Amar Gajjar
Journal: Clin Cancer Res Date: 2009-01-15 Impact factor: 12.531